Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03050983 · ClinicalTrials.gov registry record
Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 440
- Enrollment target
NCT03050983: Completed study, sponsored by Medtronic - MITG.
NCT03050983 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 440 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03050983 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 440 participants
- Enrollment target
Study Summary
Single site prospective observational nested study of bedside CS20p monitor on the GCF impeded into a retrospective review of the frequency of escalation of care with intermittent vitals signs compared to continuous respiratory monitoring.
Primary Outcome
Adjusted Hospital Length of Stay in both Phases
Interventions
- DEVICE IPI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2020-09-10 |
What the finished NCT03050983 record still lists
NCT03050983 is an observational study that tracks outcomes without assigning an intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which IPI is the first listed.
NCT03050983 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03050983 about?
NCT03050983 is a clinical study titled "Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.". Single site prospective observational nested study of bedside CS20p monitor on the GCF impeded into a retrospective review of the frequency of escalation of care with intermittent vitals signs compared to continuous respiratory monitoring.
What is the current status of trial NCT03050983?
This trial is currently completed. The enrollment target is 440 participants. The study started on 2017-02-15. Estimated completion is 2020-09-10.
What interventions are being tested in trial NCT03050983?
The interventions under investigation include: IPI (DEVICE).
Who is sponsoring clinical trial NCT03050983?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI